Table 1
| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S1304-MM,relapsed/refractory, Car+Dex | 1 | N | 1 Dex+Low Dose Carfilzomib | 140 | 72 | 0 | 0 | 0 | 0 | 0 | 02/12/2014 | ||
| 2 Dex+High Dose Carfilzomib | 71 | 0 | 0 | 0 | 0 | 0 | ||||||||
| 143 | 0 | 0 | 0 | 0 | 0 | |||||||||
| 2 | Y | 3 Dex+High Dose Carfilzomib | 140 | 22 | 0 | 0 | 0 | 0 | 0 | 02/12/2014 | ||||
| 22 | 0 | 0 | 0 | 0 | 0 | |||||||||
| S1803-MM, Maintenance, Len vs Len/Dara | 1 | Y | 0 Screening | 1100 | 445 | 330 | 210 | 103 | 24 | 4 | 08/13/2019 | 260 | 99 | |
| 445 | 330 | 210 | 103 | 24 | 4 | |||||||||
| 2 | Y | 1 Lenalidomide | 1100 | 196 | 156 | 104 | 52 | 13 | 3 | 08/13/2019 | ||||
| 2 Lenalidomide + Daratumumab | 192 | 152 | 104 | 51 | 15 | 2 | ||||||||
| 388 | 308 | 208 | 103 | 28 | 5 | |||||||||
| No | A061402-Solitary Plasmacytoma, adj sys+Zol vs Zol | 0 | E | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 01/27/2017 | |||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| EAA173-MYEL, SMM, Rd +/- Daratumumab | 0 | E | Total Registrations | 26 | 19 | 8 | 4 | 4 | 1 | 01/08/2020 | 208 | 82 | ||
| 26 | 19 | 8 | 4 | 4 | 1 | |||||||||
| 1 | E | Total Registrations | 13 | 8 | 4 | 1 | 1 | 1 | 01/08/2020 | |||||
| 13 | 8 | 4 | 1 | 1 | 1 | |||||||||